Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-013706
Filing Date
2022-05-26
Accepted
2022-05-26 20:30:06
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2729
  Complete submission text file 0001437749-22-013706.txt   4199
Mailing Address C/O ABLE LABORATORIES, INC. 6 HOLLYWOOD COURT, CN 1013 SOUTH PLAINFIELD NJ 07080
Business Address
Tierney David S (Reporting) CIK: 0001292636 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 22972249

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations